reports

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home…

7 months ago

Lexin Reports Q2 2025 Financial Results: Revenue Hits RMB 3.59B with 15.6% QoQ Growth; Profit Rises for 5 Straight Quarters as Scenario-Based Transactions Surge to Spur Consumption

Shenzhen, China , Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 7, 2025, Beijing time, Lexin (NASDAQ: LX), China’s leading…

7 months ago

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 – – Data readouts for CHS-114 and…

7 months ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 06, 2025 16:45 ET  | Source: Neuronetics MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),…

7 months ago

Gilat Reports Second Quarter 2025 Results

Revenues Increased by 37%; GAAP Operating Income of $5.7 Million; Adjusted EBITDA of $11.8 Million Raises Midpoint of 2025 Revenue…

7 months ago

Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update

Recorded second quarter 2025 worldwide revenue of $378.0 million, GAAP fully diluted earnings per share of $1.12, adjusted fully diluted…

7 months ago

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:15 ET  | Source: ImageneBio, Inc. SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq:…

7 months ago

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:08 ET  | Source: Protara Therapeutics NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.…

7 months ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:05 ET  | Source: Akebia Therapeutics, Inc. CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®,…

7 months ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:55 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE)…

7 months ago